Progression-free survival as surrogate end point for overall survival in clinical trials of HER2-targeted agents in HER2-positive metastatic breast cancer

S. Michiels, L. Pugliano, S. Marguet, D. Grun, J. Barinoff, D. Cameron, M. Cobleigh, A. Di Leo, S. Johnston, G. Gasparini, B. Kaufman, M. Marty, V. Nekljudova, S. Paluch-Shimon, F. Penault-Llorca, D. Slamon, C. Vogel, G. von Minckwitz, M. Buyse, M. Piccart

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Progression-free survival as surrogate end point for overall survival in clinical trials of HER2-targeted agents in HER2-positive metastatic breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences